Cancer Letters
Volume 253, Issue 1 , Pages 115-123 , 8 August 2007

Exploitation of drug-induced Bcl-2 overexpression for restoring normal apoptosis function: A promising new approach to the treatment of multidrug resistant cancer

  • Yaming Su

      Affiliations

    • Department of Pharmaceutics, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, 160 Frelinghuysen Road, Piscataway, NJ 08854, USA
  • ,
  • Xiaoping Zhang

      Affiliations

    • Department of Pharmaceutics, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, 160 Frelinghuysen Road, Piscataway, NJ 08854, USA
  • ,
  • Patrick J. Sinko

      Affiliations

    • Department of Pharmaceutics, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, 160 Frelinghuysen Road, Piscataway, NJ 08854, USA
    • The Cancer Institute of New Jersey, New Brunswick, NJ, USA
    • Corresponding Author InformationCorresponding author. Address: Department of Pharmaceutics, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, 160 Frelinghuysen Road, Piscataway, NJ 08854, USA. Tel.: +1 732 445 3831x213; fax: +1 732 445 4271.

Received 28 September 2006 ,Revised 16 January 2007 ,Accepted 18 January 2007.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 This work was support by The Parke-Davis Endowed Chair in Pharmaceutics and Drug Delivery and NIH AI51214.

PII: S0304-3835(07)00031-6

doi: 10.1016/j.canlet.2007.01.018

Cancer Letters
Volume 253, Issue 1 , Pages 115-123 , 8 August 2007